GSK3B and neoplasm: Mechanistically, miR-29a-3p functioned as a tumor-promoting factor by downregulating the FOXO3-AKT/GSK3β axis and subsequently suppressing the expression of PD-L1, which was a known target molecule for anti-tumor immunotherapy, to shield OC cells from immune escape.